|
|||||
|
|
Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine |
|
| Authors: | Messoud Ashina MD PhD DMSc Joshua M. Cohen MD MPH FAHS Sanjay K. Gandhi PhD Evelyn Du PhD |
| Affiliation: | 1. Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;2. Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA |
| Abstract: | |
| Keywords: | anti-calcitonin gene-related peptide fremanezumab headache severity migraine |